Maja Todorovic

921 total citations
11 papers, 401 citations indexed

About

Maja Todorovic is a scholar working on Oncology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Maja Todorovic has authored 11 papers receiving a total of 401 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 8 papers in Immunology and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Maja Todorovic's work include CAR-T cell therapy research (7 papers), Immune Cell Function and Interaction (6 papers) and Immunotherapy and Immune Responses (5 papers). Maja Todorovic is often cited by papers focused on CAR-T cell therapy research (7 papers), Immune Cell Function and Interaction (6 papers) and Immunotherapy and Immune Responses (5 papers). Maja Todorovic collaborates with scholars based in Italy, United States and France. Maja Todorovic's co-authors include Dario Sangiolo, Massimo Aglietta, Fabrizio Carnevale‐Schianca, Loretta Gammaitoni, Giulia Mesiano, Valeria Leuci, Lidia Giraudo, Franca Fagioli, Wanda Piacibello and Alessandro Cignetti and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Cancer Research.

In The Last Decade

Maja Todorovic

11 papers receiving 393 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maja Todorovic Italy 8 313 307 66 42 30 11 401
Lidia Giraudo Italy 10 270 0.9× 282 0.9× 72 1.1× 23 0.5× 20 0.7× 13 367
Sharon Merims Israel 13 296 0.9× 194 0.6× 100 1.5× 34 0.8× 20 0.7× 28 431
Y. Maurice Morillon United States 11 386 1.2× 294 1.0× 85 1.3× 77 1.8× 15 0.5× 19 527
Lois Hageman Netherlands 10 289 0.9× 315 1.0× 69 1.0× 49 1.2× 29 1.0× 14 419
Mitsuko Ideno Japan 6 409 1.3× 341 1.1× 105 1.6× 30 0.7× 27 0.9× 9 479
Erlend Strønen Norway 5 370 1.2× 339 1.1× 148 2.2× 30 0.7× 25 0.8× 7 463
John P. Veluchamy Netherlands 7 309 1.0× 281 0.9× 59 0.9× 19 0.5× 60 2.0× 9 399
Susanne Wilde Germany 13 430 1.4× 345 1.1× 142 2.2× 100 2.4× 28 0.9× 20 542
Juergen Kuball United States 3 281 0.9× 275 0.9× 65 1.0× 22 0.5× 32 1.1× 5 387
Behiye Kodal United States 10 454 1.5× 399 1.3× 55 0.8× 25 0.6× 31 1.0× 18 535

Countries citing papers authored by Maja Todorovic

Since Specialization
Citations

This map shows the geographic impact of Maja Todorovic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maja Todorovic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maja Todorovic more than expected).

Fields of papers citing papers by Maja Todorovic

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maja Todorovic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maja Todorovic. The network helps show where Maja Todorovic may publish in the future.

Co-authorship network of co-authors of Maja Todorovic

This figure shows the co-authorship network connecting the top 25 collaborators of Maja Todorovic. A scholar is included among the top collaborators of Maja Todorovic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maja Todorovic. Maja Todorovic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Leuci, Valeria, Federica Maione, Ramona Rotolo, et al.. (2016). Lenalidomide normalizes tumor vessels in colorectal cancer improving chemotherapy activity. Journal of Translational Medicine. 14(1). 119–119. 17 indexed citations
2.
Leuci, Valeria, Giulia Mesiano, Loretta Gammaitoni, et al.. (2014). Ex Vivo-Activated MHC-Unrestricted Immune Effectors for Cancer Adoptive Immunotherapy. Anti-Cancer Agents in Medicinal Chemistry. 14(2). 211–222. 2 indexed citations
3.
Gammaitoni, Loretta, Valeria Leuci, Giulia Mesiano, et al.. (2014). Immunotherapy of cancer stem cells in solid tumors: initial findings and future prospective. Expert Opinion on Biological Therapy. 14(9). 1259–1270. 18 indexed citations
4.
Gammaitoni, Loretta, Lidia Giraudo, Valeria Leuci, et al.. (2013). Effective Activity of Cytokine-Induced Killer Cells against Autologous Metastatic Melanoma Including Cells with Stemness Features. Clinical Cancer Research. 19(16). 4347–4358. 80 indexed citations
5.
Leuci, Valeria, Federica Maione, Maja Todorovic, et al.. (2013). Preclinical activity of lenalidomide in metastatic colorectal cancer.. Journal of Clinical Oncology. 31(15_suppl). e14654–e14654. 2 indexed citations
6.
Mesiano, Giulia, Maja Todorovic, Loretta Gammaitoni, et al.. (2012). Cytokine-induced killer (CIK) cells as feasible and effective adoptive immunotherapy for the treatment of solid tumors. Expert Opinion on Biological Therapy. 12(6). 673–684. 122 indexed citations
7.
Todorovic, Maja, Giulia Mesiano, Loretta Gammaitoni, et al.. (2012). Ex Vivo Allogeneic Stimulation Significantly Improves Expansion of Cytokine-Induced Killer Cells Without Increasing Their Alloreactivity Across HLA Barriers. Journal of Immunotherapy. 35(7). 579–586. 20 indexed citations
8.
Leuci, Valeria, Giulia Mesiano, Loretta Gammaitoni, et al.. (2011). Transient proteasome inhibition as a strategy to enhance lentiviral transduction of hematopoietic CD34+ cells and T lymphocytes: Implications for the use of low viral doses and large-size vectors. Journal of Biotechnology. 156(3). 218–226. 13 indexed citations
9.
Circosta, Paola, Luisa Granziero, Antonia Follenzi, et al.. (2009). T Cell Receptor (TCR) Gene Transfer with Lentiviral Vectors Allows Efficient Redirection of Tumor Specificity in Naive and Memory T Cells Without Prior Stimulation of Endogenous TCR. Human Gene Therapy. 20(12). 1576–1588. 28 indexed citations
10.
Sangiolo, Dario, Giorgio Valabrega, Giuliana Cavalloni, et al.. (2009). MIC A/B Protein Expression Associates with Trastuzumab-Resistant Breast Cancer Cells Leading to Effective Immunotherapy by Cytokine Induced Killer Cells.. Blood. 114(22). 4092–4092. 1 indexed citations
11.
Sangiolo, Dario, Emanuela Martinuzzi, Maja Todorovic, et al.. (2008). Alloreactivity and anti-tumor activity segregate within two distinct subsets of cytokine-induced killer (CIK) cells: implications for their infusion across major HLA barriers. International Immunology. 20(7). 841–848. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lidia Giraudo Breakdown of academic impact, for papers by Sharon Merims Breakdown of academic impact, for papers by Y. Maurice Morillon Breakdown of academic impact, for papers by Lois Hageman Breakdown of academic impact, for papers by Mitsuko Ideno Breakdown of academic impact, for papers by Erlend Strønen Breakdown of academic impact, for papers by John P. Veluchamy Breakdown of academic impact, for papers by Susanne Wilde Breakdown of academic impact, for papers by Juergen Kuball Breakdown of academic impact, for papers by Behiye Kodal
Rankless by CCL
2026